• Aspergillus DNA, Qualitative, Real-Time PCR, Sputum
  • Bromazepam
  • Zika Virus IgM Antibody, IgM
  • Estradiol, Serum
  • Coagulation Factor XI Inhibitor Screen, Plasma
  • Bacterial Culture, Cerebrospinal Fluid (CSF)
  • Phenosense Combination HIV Drug Resistance Assay
  • Toxoplasma gondii Antibody, IgM
  • Tobramycin, Trough, Serum
  • Islet Cell (IA-2) Autoantibodies
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

Interpretation
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.